Treatment Details – 18.0 months

Survival: 18.0 months
  
Toxicity Grade:3
  
Treatments: Immunotherapy
  
Drugs:
Country:France
  
City/State/Province:Marseille
  
Hospital:Hopital de la Conception
  
Journal:Link
  
Date: 11/1998

Description:
Patients: This Phase II study involved 22 patients with malignant pleural mesothelioma.

Treatment: The treatment consisted of the intrapleural administration of interleukin-2. (Interleukin-2 is a cytokine or immune system messenger which encourages the proliferation of CD4 cells.)

Toxicity: Grade 3 toxicities included cardiovascular, weight gain, sepsis, and cutaneous.

Results: The overall median survival time was 18 months.

Get your free copy of
“Surviving Mesothelioma” Today!